Browsing Pharmaceutical Sciences by Subject "Anti-obesity medications (AOM), Liraglutide (Saxenda), Naltrexone-bupropion (Contrave), Obesity, Orlistat (Xenical), Overweight, Phentermine (Ponderax), Phentermine-topiramate (Qsymia), Semaglutide (Wegovy), Setmelanotide (IMCIVREE), Tirzepatide (Mounjaro), Type 2 diabetes mellitus (T2DM)"
Now showing items 1-1 of 1
-
A narrative review of approved and emerging anti-obesity medications
(Elsevier B.V., 2023)Background: Recently, many drugs have been approved for halting overweight and obesity—few types of research shifted to using Anti-obesity medications (AOM) solely for well-being and shape-keeping. Objective: This narrative ...